Guidelines on severity assessment and classification of genetically altered mice and rat lines
|Category:||Ethics & harm-benefit analysis|
Genetic alteration of laboratory rodents may affect their welfare. In compliance with EU Directive 2010/63, potentially harmful phenotypes must be characterised and their effects reduced to what is strictly necessary for the experiment.
These guidelines have been produced by the Working Group of Berlin Animal Welfare Officers. The latest revision, version 1.1 of 1 May 2017, has been accepted for publication in Laboratory Animals. In addition to background information on severity classification, they include examples of the classification of the symptoms in a range of disorders: lethal factors, behavioural disorders, alterations of the skin and coat, diseases of the sensory organs, neurological diseases, diseases of the immune system, cardiovascular and haematological diseases, diseases of the respiratory tract, metabolic diseases, reproductive diseases, cancer, renal diseases and alterations of the locomotor system.
The Guidelines also include Recommendations on the number of animals required to evaluate an increase in harmful phenotypes in mouse and rat lines, and a large number of literature references.
These Guidelines reflect the Group's initial experiences in defining the severity degrees of genetically altered lines and should prove useful when assigning categories of severity to animal studies. Line-specific properties, varying manifestation of symptoms and institution-specific housing conditions must be taken into account when the severity degree is selected.
The Group welcome feedback on the categories of severity mentioned in the Guidelines, and further examples. The Guidelines will be continuously reviewed and extended.
Fant du det du lette etter?Ja, jeg fant det! Nei, jeg fant det ikke!
Takk for din tilbakemelding! Vær oppmerksom på at vi ikke kan kontakte deg hvis ikke du oppgir din epostadresse.
Hva lette du etter?
Gi oss gjerne en tilbakemelding slik at vi kan forbedre informasjonen på siden. På forhånd takk for hjelpen! Vennligst skriv inn din epostadresse hvis du vil ha et svar.Kontakt oss gjerne på e-post hvis du har spørsmål.